USE OF INTERFERON TAU FOR THE MANUFACTURE OF A MEDICAMENT IN COMBINATION WITH INTERFERON-ALPHA OR INTERFERON-BETA FOR REDUCTION OF THEIR ADVERSE EFFECTS

摘要

A method of treating conditions responsive to therapy with interferon-alpha o interferon-beta is provided, where the dose of interferon-alpha or interferon-beta i increased and a dose of interferon-tau is additionally administered. The method results in efficacious thera with a reduction in unwanted adverse events.